{"entity":{"type":"insider","cik":"0001257242","url":"/insider/0001257242","json_url":"/insider/0001257242.json","name":"DURUS LIFE SCIENCES MASTER FUND LTD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2121,"n_filings":82,"first":"2003-10-30","last":"2004-11-19","span_basis":"filed_date"},"name_variants":[{"name":"DURUS LIFE SCIENCES MASTER FUND LTD","source":"filing","n_filings":82,"first_seen":"2003-10-30","last_seen":"2004-11-19"}],"transactions":[{"id":235898,"accession":"0000902664-04-001747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-04-001747","line_url":"/filing/0000902664-04-001747#line-1","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":165000.0,"shares_display":"165,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":990000.0,"total_display":"990,000.00","total_whole":"990,000","shares_owned_after":21498118.0,"shares_owned_after_display":"21,498,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-18","filed_date":"2004-11-19","scope":"insider"},{"id":8995,"accession":"0000902664-03-001563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-03-001563","line_url":"/filing/0000902664-03-001563#line-1","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":2.4292,"price_display":"2.43","price_state":"stated","total_value":364380.0,"total_display":"364,380.00","total_whole":"364,380","shares_owned_after":2473000.0,"shares_owned_after_display":"2,473,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-29","filed_date":"2003-10-30","scope":"insider"},{"id":115847,"accession":"0000902664-03-001562","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-13","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87000.0,"shares_display":"87,000","price_per_share":2.4738,"price_display":"2.47","price_state":"stated","total_value":215220.6,"total_display":"215,220.60","total_whole":"215,221","shares_owned_after":2623000.0,"shares_owned_after_display":"2,623,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-28","filed_date":"2003-10-30","scope":"insider"},{"id":115846,"accession":"0000902664-03-001562","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290000.0,"shares_display":"290,000","price_per_share":2.4819827586206897,"price_display":"2.48","price_state":"stated","total_value":719775.0,"total_display":"719,775.00","total_whole":"719,775","shares_owned_after":2800000.0,"shares_owned_after_display":"2,800,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-25","filed_date":"2003-10-30","scope":"insider","n_lines":3},{"id":198442,"accession":"0000902664-03-001614","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11400.0,"shares_display":"11,400","price_per_share":15.778192105263157,"price_display":"15.78","price_state":"stated","total_value":179871.39,"total_display":"179,871.39","total_whole":"179,871","shares_owned_after":21333118.0,"shares_owned_after_display":"21,333,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":198440,"accession":"0000902664-03-001614","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":252100.0,"shares_display":"252,100","price_per_share":15.036852677508925,"price_display":"15.04","price_state":"stated","total_value":3790790.56,"total_display":"3,790,790.56","total_whole":"3,790,791","shares_owned_after":21230818.0,"shares_owned_after_display":"21,230,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":176944,"accession":"0000902664-03-001587","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587#line-19","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43078.0,"shares_display":"43,078","price_per_share":19.7173,"price_display":"19.72","price_state":"stated","total_value":849381.8494,"total_display":"849,381.85","total_whole":"849,382","shares_owned_after":9370000.0,"shares_owned_after_display":"9,370,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-10-30","scope":"insider"},{"id":198438,"accession":"0000902664-03-001614","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-13","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79700.0,"shares_display":"79,700","price_per_share":15.6357,"price_display":"15.64","price_state":"stated","total_value":1246165.29,"total_display":"1,246,165.29","total_whole":"1,246,165","shares_owned_after":21092418.0,"shares_owned_after_display":"21,092,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-10-30","scope":"insider"},{"id":198437,"accession":"0000902664-03-001614","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-12","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31800.0,"shares_display":"31,800","price_per_share":15.545,"price_display":"15.54","price_state":"stated","total_value":494331.0,"total_display":"494,331.00","total_whole":"494,331","shares_owned_after":21172118.0,"shares_owned_after_display":"21,172,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-10-30","scope":"insider"},{"id":176943,"accession":"0000902664-03-001587","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158600.0,"shares_display":"158,600","price_per_share":19.410498108448927,"price_display":"19.41","price_state":"stated","total_value":3078505.0,"total_display":"3,078,505.00","total_whole":"3,078,505","shares_owned_after":9413078.0,"shares_owned_after_display":"9,413,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-10-30","scope":"insider","n_lines":3},{"id":176940,"accession":"0000902664-03-001587","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587#line-15","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7300.0,"shares_display":"7,300","price_per_share":19.414,"price_display":"19.41","price_state":"stated","total_value":141722.2,"total_display":"141,722.20","total_whole":"141,722","shares_owned_after":9571678.0,"shares_owned_after_display":"9,571,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-10-30","scope":"insider"},{"id":115843,"accession":"0000902664-03-001562","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-9","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82270.0,"shares_display":"82,270","price_per_share":2.4434,"price_display":"2.44","price_state":"stated","total_value":201018.518,"total_display":"201,018.52","total_whole":"201,019","shares_owned_after":3000000.0,"shares_owned_after_display":"3,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-10-30","scope":"insider"},{"id":198436,"accession":"0000902664-03-001614","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-11","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25885.0,"shares_display":"25,885","price_per_share":15.283,"price_display":"15.28","price_state":"stated","total_value":395600.455,"total_display":"395,600.46","total_whole":"395,600","shares_owned_after":21140318.0,"shares_owned_after_display":"21,140,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider"},{"id":198435,"accession":"0000902664-03-001614","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68600.0,"shares_display":"68,600","price_per_share":15.1859,"price_display":"15.19","price_state":"stated","total_value":1041752.74,"total_display":"1,041,752.74","total_whole":"1,041,753","shares_owned_after":21155203.0,"shares_owned_after_display":"21,155,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":176939,"accession":"0000902664-03-001587","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99600.0,"shares_display":"99,600","price_per_share":19.181521084337348,"price_display":"19.18","price_state":"stated","total_value":1910479.5,"total_display":"1,910,479.50","total_whole":"1,910,480","shares_owned_after":9566478.0,"shares_owned_after_display":"9,566,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":176937,"accession":"0000902664-03-001587","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587#line-12","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":32300.0,"total_display":"32,300.00","total_whole":"32,300","shares_owned_after":9663978.0,"shares_owned_after_display":"9,663,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider"},{"id":115842,"accession":"0000902664-03-001562","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-8","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":2.5203,"price_display":"2.52","price_state":"stated","total_value":158778.9,"total_display":"158,778.90","total_whole":"158,779","shares_owned_after":3082270.0,"shares_owned_after_display":"3,082,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider"},{"id":115841,"accession":"0000902664-03-001562","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-7","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":248.0,"total_display":"248.00","total_whole":"248","shares_owned_after":3145270.0,"shares_owned_after_display":"3,145,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-10-30","scope":"insider"},{"id":198433,"accession":"0000902664-03-001614","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-8","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20500.0,"shares_display":"20,500","price_per_share":15.0165,"price_display":"15.02","price_state":"stated","total_value":307838.25,"total_display":"307,838.25","total_whole":"307,838","shares_owned_after":21097603.0,"shares_owned_after_display":"21,097,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-10-30","scope":"insider"},{"id":198432,"accession":"0000902664-03-001614","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":192900.0,"shares_display":"192,900","price_per_share":14.9915,"price_display":"14.99","price_state":"stated","total_value":2891860.35,"total_display":"2,891,860.35","total_whole":"2,891,860","shares_owned_after":21088103.0,"shares_owned_after_display":"21,088,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":176936,"accession":"0000902664-03-001587","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44900.0,"shares_display":"44,900","price_per_share":19.392552338530066,"price_display":"19.39","price_state":"stated","total_value":870725.6,"total_display":"870,725.60","total_whole":"870,726","shares_owned_after":9662278.0,"shares_owned_after_display":"9,662,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-10-30","scope":"insider","n_lines":3},{"id":176933,"accession":"0000902664-03-001587","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72900.0,"shares_display":"72,900","price_per_share":19.1185,"price_display":"19.12","price_state":"stated","total_value":1393738.65,"total_display":"1,393,738.65","total_whole":"1,393,739","shares_owned_after":9696178.0,"shares_owned_after_display":"9,696,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":115840,"accession":"0000902664-03-001562","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124400.0,"shares_display":"124,400","price_per_share":2.543929421221865,"price_display":"2.54","price_state":"stated","total_value":316464.82,"total_display":"316,464.82","total_whole":"316,465","shares_owned_after":3145170.0,"shares_owned_after_display":"3,145,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":198430,"accession":"0000902664-03-001614","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-5","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35500.0,"shares_display":"35,500","price_per_share":14.4449,"price_display":"14.44","price_state":"stated","total_value":512793.95,"total_display":"512,793.95","total_whole":"512,794","shares_owned_after":20925203.0,"shares_owned_after_display":"20,925,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-10-30","scope":"insider"},{"id":198429,"accession":"0000902664-03-001614","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-4","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65500.0,"shares_display":"65,500","price_per_share":14.1283,"price_display":"14.13","price_state":"stated","total_value":925403.65,"total_display":"925,403.65","total_whole":"925,404","shares_owned_after":20960703.0,"shares_owned_after_display":"20,960,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-10-30","scope":"insider"},{"id":176931,"accession":"0000902664-03-001587","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41900.0,"shares_display":"41,900","price_per_share":19.664342243436753,"price_display":"19.66","price_state":"stated","total_value":823935.94,"total_display":"823,935.94","total_whole":"823,936","shares_owned_after":9634278.0,"shares_owned_after_display":"9,634,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":176929,"accession":"0000902664-03-001587","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587#line-4","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17300.0,"shares_display":"17,300","price_per_share":19.6162,"price_display":"19.62","price_state":"stated","total_value":339360.26,"total_display":"339,360.26","total_whole":"339,360","shares_owned_after":9676178.0,"shares_owned_after_display":"9,676,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-10-30","scope":"insider"},{"id":115838,"accession":"0000902664-03-001562","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-4","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54100.0,"shares_display":"54,100","price_per_share":2.7966,"price_display":"2.80","price_state":"stated","total_value":151296.06,"total_display":"151,296.06","total_whole":"151,296","shares_owned_after":3269570.0,"shares_owned_after_display":"3,269,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-10-30","scope":"insider"},{"id":198428,"accession":"0000902664-03-001614","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13452.0,"shares_display":"13,452","price_per_share":13.931132917038358,"price_display":"13.93","price_state":"stated","total_value":187401.6,"total_display":"187,401.60","total_whole":"187,402","shares_owned_after":20896355.0,"shares_owned_after_display":"20,896,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":198426,"accession":"0000902664-03-001614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-03-001614","line_url":"/filing/0000902664-03-001614#line-1","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":13.9394,"price_display":"13.94","price_state":"stated","total_value":243939.5,"total_display":"243,939.50","total_whole":"243,940","shares_owned_after":20908655.0,"shares_owned_after_display":"20,908,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider"},{"id":176928,"accession":"0000902664-03-001587","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587#line-3","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":19.704,"price_display":"19.70","price_state":"stated","total_value":285708.0,"total_display":"285,708.00","total_whole":"285,708","shares_owned_after":9658878.0,"shares_owned_after_display":"9,658,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider"},{"id":176927,"accession":"0000902664-03-001587","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-03-001587","line_url":"/filing/0000902664-03-001587","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85500.0,"shares_display":"85,500","price_per_share":19.7391,"price_display":"19.74","price_state":"stated","total_value":1687693.05,"total_display":"1,687,693.05","total_whole":"1,687,693","shares_owned_after":9660378.0,"shares_owned_after_display":"9,660,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider","n_lines":2},{"id":130671,"accession":"0000902664-03-001613","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000902664-03-001613","line_url":"/filing/0000902664-03-001613#line-30","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":99700.0,"shares_display":"99,700","price_per_share":13.9394,"price_display":"13.94","price_state":"stated","total_value":1389758.18,"total_display":"1,389,758.18","total_whole":"1,389,758","shares_owned_after":20891155.0,"shares_owned_after_display":"20,891,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider"},{"id":115837,"accession":"0000902664-03-001562","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-03-001562","line_url":"/filing/0000902664-03-001562#line-3","is_derivative":false,"issuer_cik":"0001097264","issuer_name":"ALLOS THERAPEUTICS INC","issuer_ticker":"ALTH","issuer_name_source":null,"issuer_url":"/issuer/0001097264","owner_cik":"0001257242","owner_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_display_name":"DURUS LIFE SCIENCES MASTER FUND LTD","owner_url":"/insider/0001257242","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74630.0,"shares_display":"74,630","price_per_share":2.7909,"price_display":"2.79","price_state":"stated","total_value":208284.867,"total_display":"208,284.87","total_whole":"208,285","shares_owned_after":3323670.0,"shares_owned_after_display":"3,323,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-10-30","scope":"insider"}],"collapsed":true,"next_cursor":"2003-07-17|115837","ledger_fault":false,"count":{"value":2121,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1746,"open_market":true},{"code":"S","label":"Open-market sale","n":375,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2121},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000902600","name":"AKSYS LTD","url":"/issuer/0000902600","role":"Ten percent owner","n_filings":27,"first_seen":"2003-10-30","last_seen":"2004-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000918066","name":"GUILFORD PHARMACEUTICALS INC","url":"/issuer/0000918066","role":"Ten percent owner","n_filings":2,"first_seen":"2003-10-30","last_seen":"2003-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001012131","name":"NOVOSTE CORP /FL/","url":"/issuer/0001012131","role":"Ten percent owner","n_filings":8,"first_seen":"2003-10-30","last_seen":"2003-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001066745","name":"ESPERION THERAPEUTICS INC/MI","url":"/issuer/0001066745","role":"Ten percent owner","n_filings":23,"first_seen":"2003-10-30","last_seen":"2003-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001097264","name":"ALLOS THERAPEUTICS INC","url":"/issuer/0001097264","role":"Ten percent owner","n_filings":22,"first_seen":"2003-10-30","last_seen":"2003-10-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001257242","retrieved_at":"2026-08-26T13:54:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}